Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Boursi

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 11, 2018
Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600-mutant metastatic melanomaGuy Ben-Betzalel, Erez N Baruch, Ben Boursi, et al.
European Journal of Gastroenterology & Hepatology|January 20, 2021
A clinical prediction model to assess risk for pancreatic cancer among patients with prediabetesBen Boursi, Brian Finkelman, Bruce J Giantonio, et al.
Journal of Traumatic Stress|December 7, 2018
Posttraumatic Stress Disorder and Cancer Risk: A Nested Case-Control StudyElana Cohn, Ido Lurie, Yu-Xiao Yang, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2024
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patientsOfer Margalit, Amos Stemmer, William J Chapin, et al.
Clinical Colorectal Cancer|February 20, 2021
Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal CancerShun Yu, Ronac Mamtani, Mark H O'Hara, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2020
Locoregional Treatments and Ipsilateral Breast Cancer Recurrence Rates in BRCA1/2 Mutation CarriersRinat Bernstein-Molho, Yael Laitman, Shira Galper, et al.
Plos One|February 16, 2018
Functional imaging of the interaction between gut microbiota and the human host: A proof-of-concept clinical study evaluating novel use for 18F-FDG PET-CTBen Boursi, Thomas J Werner, Saeid Gholami, et al.
Cancer|October 28, 2016
Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710Eric Ojerholm, Andrew Smith, Wei-Ting Hwang, et al.
The Journal of Surgical Research|August 8, 2022
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Elderly is Safe and EffectiveShachar Laks, Alona Bilik, Gal Schtrechman, et al.
European Journal of Cancer (Oxford, England : 1990)|April 27, 2018
A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancerOfer Margalit, Ronac Mamtani, Yu-Xiao Yang, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|August 11, 2018
Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600-mutant metastatic melanomaGuy Ben-Betzalel, Erez N Baruch, Ben Boursi, et al.
European Journal of Gastroenterology & Hepatology|January 20, 2021
A clinical prediction model to assess risk for pancreatic cancer among patients with prediabetesBen Boursi, Brian Finkelman, Bruce J Giantonio, et al.
Journal of Traumatic Stress|December 7, 2018
Posttraumatic Stress Disorder and Cancer Risk: A Nested Case-Control StudyElana Cohn, Ido Lurie, Yu-Xiao Yang, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2024
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patientsOfer Margalit, Amos Stemmer, William J Chapin, et al.
Clinical Colorectal Cancer|February 20, 2021
Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal CancerShun Yu, Ronac Mamtani, Mark H O'Hara, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2020
Locoregional Treatments and Ipsilateral Breast Cancer Recurrence Rates in BRCA1/2 Mutation CarriersRinat Bernstein-Molho, Yael Laitman, Shira Galper, et al.
Plos One|February 16, 2018
Functional imaging of the interaction between gut microbiota and the human host: A proof-of-concept clinical study evaluating novel use for 18F-FDG PET-CTBen Boursi, Thomas J Werner, Saeid Gholami, et al.
Cancer|October 28, 2016
Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710Eric Ojerholm, Andrew Smith, Wei-Ting Hwang, et al.
The Journal of Surgical Research|August 8, 2022
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Elderly is Safe and EffectiveShachar Laks, Alona Bilik, Gal Schtrechman, et al.
European Journal of Cancer (Oxford, England : 1990)|April 27, 2018
A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancerOfer Margalit, Ronac Mamtani, Yu-Xiao Yang, et al.
Pageof 11